The therapeutic approach was safe, but the study did not meet its primary efficacy outcome using the six-minute walking test.

Having any sleep disorder was independently linked to a higher likelihood for developing aortic stenosis, although dyslipidemia appeared to be an important mediator of the risk Data from the ...

Researchers found that at five years, patients with severe aortic stenosis who were treated with either TAVR or surgery had comparable rates of all-cause mortality or disabling stroke.

A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic stenosis, a valvular heart condition that can be deadly ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had ...

A first-of-its-kind therapy successfully slowed plaque progression in patients with aortic stenosis. Ataciguat may reduce the need for surgical or transcatheter aortic valve replacement.

A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used ...

BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of ...